Magnetic Resonance Imaging and Breast Ultrasonography as an Adjunct to Mammographic Screening in High-Risk Patients

Seminars in Ultrasound, CT and MRI

Volumn 32, Issue 4, 2011, Pages 266-272

  Le Petross, Huong T ^a   Shetty, Mahesh K ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Woman's Hospital of Texas   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ECHOMAMMOGRAPHY; FALSE POSITIVE RESULT; HEALTH CARE ACCESS; HEALTH CARE COST; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; INTRADUCTAL CARCINOMA; MAGNETIC FIELD; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RADIOLOGIST; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

BREAST; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; RISK FACTORS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, MAMMARY;

EID: 79960530782     PISSN: 08872171     EISSN: 15585034     Source Type: Journal    
DOI: 10.1053/j.sult.2011.03.005     Document Type: Article

References (41)

1. Kuhl C.K., Kuhn W., Schild H. Management of women at high risk for breast cancer: New imaging beyond mammography. Breast 2005, 14:480-486.
2. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57:75-89.
3. Gail M.H., Brinton L.A., Byar D.P., et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886.
4. Claus E.B., Risch N., Thompson W.D. Autosomal dominant inheritance of early-onset breast cancer: Implications for risk prediction. Cancer 1994, 73:643-651.
5. Berry D.A., Iversen E.S., Gudbjartsson D.F., et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 2002, 20:2701-2712.
6. Tyrer J., Duffy S.W., Cuzick J., et al. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004, 23:1111-1130.
7. Swerdlow A.J., Douglas A.J., Hudson G.V., et al. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. BMJ 1992, 304:1137-1143.
8. Tucker M.A., Coleman C.N., Cox R.S., et al. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med 1988, 318:76-81.
9. van Leeuwen F.E., Klokman W.J., Hagenbeek A., et al. Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 1994, 12:312-325.
10. Ng A.K., Bernardo M.V., Weller E., et al. Second malignancies after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors. Blood 2002, 100:1989-1996.
11. Warner E., Plewes D.B., Shumak R.S., et al. Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001, 19:3524-3531.
12. Stoutjesdijk M.J., Boetes C., Jager G.J., et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001, 18:1095-1102.
13. Rijnsburger A.J., Obdeijn I.M., Kaas R., et al. BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: Long-term follow-up of the Dutch MRISC screening study. J Clin Oncol 2010, 28:5265-5273.
14. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: A prospective multicentre cohort study (MARIBS). Lancet 2005, 365:1769-1778.
15. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004, 292:1317-1325.
16. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23:8469-8476.
17. Kriege M., Brekelmans C., Boetes C., et al. Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351:427-437.
18. Sardanelli F., Podo F., D'Agnolo G., et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): Interim results. Radiology 2007, 242:698-715.
19. Sardanelli F., Podo F., Santoro F., et al. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the High Breast Cancer Risk Italian 1 study): Final results. Invest Radiol 2011, 46:94-105.
20. Weinstein S.P., Localio A.R., Conant E.F., et al. Multimodality screening of high-risk women: A prospective cohort study. J Clin Oncol 2009, 27:6124-6128.
21. Lehman C.D., Isaacs C., Schnall M.D., et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007, 244:381-388.
22. Lehman C.D., Blume J.D., Thickman D., et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: Results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol 2005, 92:9-15.
23. Warner E., Messersmith H., Plewes D.B., et al. Magnetic resonance imaging screening of women at high risk for breast cancer: A systematic review. Ann Intern Med 2008, 148:671-679.
24. Schrading S., Kuhl C.K. Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology 2008, 246:58-70.
25. Gilbert F., Warren R., Kwan-Lim G., et al. Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features. Radiology 2009, 252:358-368.
26. Veltman J., Mann R., Kok T., et al. Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI. Eur Radiol 2008, 18:931-938.
27. Kriege M., Brekelmans C.T., Peterse H., et al. Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res Treat 2007, 102:357-363.
28. Kuhl C.K., Schrading S., Bieling H.B., et al. MRI for diagnosis of pure ductal carcinoma in situ: A prospective observational study. Lancet 2007, 370:485-492.
29. Elmore J.G., Armstrong K., Lehman C.D., et al. Screening for breast cancer. JAMA 2005, 293:1245-1256.
30. Kuhl C.K. The "coming of age" of nonmammographic screening for breast cancer. JAMA 2008, 299:2203-2205.
31. Nothacker M., Duda V., Hahn M., et al. Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue: A systematic review. BMC Cancer 2009, 9:1-9.
32. Gordan P.B. Ultrasound for breast cancer screening and staging. Radiol Clin North Am 2002, 40:431-441.
33. Boyd N.F., Guo H., Martin L.J., et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007, 356:227-236.
34. Berg W.A. Beyond standard mammographic screening: Mammography at age extremes, ultrasound, and MR imaging. Radiol Clin North Am 2007, 45:895-906.
35. Berg W.A., Blume J.D., Cormack J.B., et al. Combined screening with ultrasound and mammography vs mammography alone in women with elevated risk of breast cancer. JAMA 2008, 299:2151-2163.
36. Tohno E., Ueno E., Watanabe H. Ultrasound screening of breast cancer. Breast Cancer 2009, 16:18-22.
37. Tunoda H., Tohno E., Ueno E., et al. Examination of effectiveness of breast cancer detection by modalities and age groups. J Jpn Association Breast Cancer Screen 1998, 7:281-285.
38. Osako T., Takahashi K., Iwase T., et al. Diagnostic ultrasonography and mammography for invasive and noninvasive breast cancer in women aged 30 to 39 years. Breast Cancer 2007, 14:229-233.
39. Corsetti V., Ferrari A., Ghirardi M., et al. Role of ultrasonography in detecting mammographically occult breast carcinoma in women with dense breasts. Radiol Med (Torino) 2006, 111:440-448.
40. Berg W.A. Supplemental screening sonography in dense breasts. Radiol Clin North Am 2004, 42:845-851.
41. Menell J.H., Morris E.A., Dershaw D.D., et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005, 11:382-390.